{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:06:33Z","timestamp":1758931593573,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Provincial First People's Hospital Clinical Medical Center for Thoracic Diseases","award":["2022LCZXKF-XB01"],"award-info":[{"award-number":["2022LCZXKF-XB01"]}]},{"name":"the Joint Foundation of Science & Technology Department of Yunnan Province and Kunming Medical University","award":["202301AY070001-231, 202401AY070001-257"],"award-info":[{"award-number":["202301AY070001-231, 202401AY070001-257"]}]},{"name":"Yunnan Provincial Clinical Research Center for Respiratory System Diseases","award":["2023YJZX-HX01"],"award-info":[{"award-number":["2023YJZX-HX01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03116-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:45:10Z","timestamp":1758876310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs"],"prefix":"10.1186","volume":"30","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"3116_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, et al. Lung cancer statistics, 2023. Cancer. 2024;130:1330\u201348.","journal-title":"Cancer"},{"key":"3116_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3116_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN Guidelines\u00ae insights: non-small cell lung cancer, version 2.2023. J Natl Compr Cancer Netw. 2023;21:340\u201350.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3116_CR4","volume":"29","author":"L Durbin","year":"2021","unstructured":"Durbin L, Murali B, Li S, Zhao L, Hawthorne S, Kanas G, et al. Treatment patterns in non-small-cell lung cancer in China: results from the CancerMPact survey 2020. Cancer Treat Res Commun. 2021;29:100462.","journal-title":"Cancer Treat Res Commun"},{"key":"3116_CR5","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.3390\/jcm13154476","volume":"13","author":"I Attili","year":"2024","unstructured":"Attili I, Asnaghi R, Vacirca D, Adorisio R, Rappa A, Ranghiero A, et al. Co-occurring driver genomic alterations in advanced non-small-cell lung cancer (NSCLC): a retrospective analysis. J Clin Med. 2024;13:4476.","journal-title":"J Clin Med"},{"key":"3116_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/1386207325666220609120001","volume":"26","author":"D Zhao","year":"2023","unstructured":"Zhao D, Wang T, Zhang X, Liu W, Sun C, Li Z. Prognostic and immunological significance of rhomboid domain containing protein 1 in multiple primary cancers. Comb Chem High Throughput Screen. 2023;26:682\u201395.","journal-title":"Comb Chem High Throughput Screen"},{"key":"3116_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12466","volume":"24","author":"M Li","year":"2021","unstructured":"Li M, Cai L, Wang X, Yu Y, Jian W, Bao G, et al. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR\/AKT signaling pathway. Mol Med Rep. 2021;24:1\u20139.","journal-title":"Mol Med Rep"},{"key":"3116_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5114\/fn.2022.118186","volume":"60","author":"L Chen","year":"2022","unstructured":"Chen L, Wang X, Zhu Y, Liu F, Liu L, Jiang N. Effects of miR-211-3p\/RHBDD1 axis on cell proliferation, cell cycle progression, and epithelial-mesenchymal transition in glioma. Folia Neuropathol. 2022;60:195\u2013209.","journal-title":"Folia Neuropathol"},{"key":"3116_CR9","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/tox.23541","volume":"37","author":"J Jiang","year":"2022","unstructured":"Jiang J, Cheng Y, Dai S, Zou B, Guo X. Suppression of rhomboid domain-containing 1 produces anticancer effects in pancreatic adenocarcinoma through affection of the AKT\/GSK-3\u03b2\/\u03b2-catenin pathway. Environ Toxicol. 2022;37:1944\u201356.","journal-title":"Environ Toxicol"},{"key":"3116_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-020-00229-6","volume":"25","author":"S Xu","year":"2020","unstructured":"Xu S, Zhang H, Wang A, Ma Y, Gan Y, Li G. Silibinin suppresses epithelial\u2013mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1. Cell Mol Biol Lett. 2020;25:36.","journal-title":"Cell Mol Biol Lett"},{"key":"3116_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10735-020-09943-z","volume":"52","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang R, Li X, Yang L, Peng H, Wang Y, et al. Rhbdd1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1\/PI3K\/AKT signaling pathway. J Mol Histol. 2021;52:503\u201310.","journal-title":"J Mol Histol"},{"key":"3116_CR12","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1042\/BCJ20160237","volume":"473","author":"JJ Lim","year":"2016","unstructured":"Lim JJ, Lee Y, Ly TT, Kang JY, Lee J-G, An JY, et al. Structural insights into the interaction of p97 N-terminus domain and VBM in rhomboid protease, RHBDL4. Biochem J. 2016;473:2863\u201380.","journal-title":"Biochem J"},{"key":"3116_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molcel.2012.06.008","volume":"47","author":"L Fleig","year":"2012","unstructured":"Fleig L, Bergbold N, Sahasrabudhe P, Geiger B, Kaltak L, Lemberg MK. Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins. Mol Cell. 2012;47:558\u201369.","journal-title":"Mol Cell"},{"key":"3116_CR14","doi-asserted-by":"publisher","first-page":"27342","DOI":"10.1038\/srep27342","volume":"6","author":"L Wunderle","year":"2016","unstructured":"Wunderle L, Knopf JD, K\u00fchnle N, Morl\u00e9 A, Hehn B, Adrain C, et al. Rhomboid intramembrane protease RHBDL4 triggers ER-export and non-canonical secretion of membrane-anchored TGF\u03b1. Sci Rep. 2016;6:27342.","journal-title":"Sci Rep"},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-022-04414-9","volume":"602","author":"S Tang","year":"2022","unstructured":"Tang S, Beattie AT, Kafkova L, Petris G, Huguenin-Dezot N, Fiedler M, et al. Mechanism-based traps enable protease and hydrolase substrate discovery. Nature. 2022;602:701\u20137.","journal-title":"Nature"},{"key":"3116_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.devcel.2012.08.015","volume":"23","author":"YC Tsai","year":"2012","unstructured":"Tsai YC, Weissman AM. A ubiquitin-binding rhomboid protease aimed at ERADication. Dev Cell. 2012;23:454\u20136.","journal-title":"Dev Cell"},{"key":"3116_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41467-024-45615-2","volume":"15","author":"JD Knopf","year":"2024","unstructured":"Knopf JD, Steigleder SS, Korn F, K\u00fchnle N, Badenes M, Tauber M, et al. RHBDL4-triggered downregulation of COPII adaptor protein TMED7 suppresses TLR4-mediated inflammatory signaling. Nat Commun. 2024;15:1528.","journal-title":"Nat Commun"},{"key":"3116_CR18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3390\/biom11101528","volume":"11","author":"M Sen","year":"2021","unstructured":"Sen M, Kutsyr O, Cao B, Bolz S, Arango-Gonzalez B, Ueffing M. Pharmacological inhibition of the VCP\/proteasome axis rescues photoreceptor degeneration in RHO(P23H) rat retinal explants. Biomolecules. 2021;11:1528.","journal-title":"Biomolecules"},{"key":"3116_CR19","doi-asserted-by":"crossref","unstructured":"Benitez DA, Cumplido-Laso G, Olivera-G\u00f3mez M, Del Valle-Del Pino N, D\u00edaz-Pizarro A, Mulero-Navarro S, Rom\u00e1n-Garc\u00eda A, Carvajal-Gonzalez JM. p53 genetics and biology in lung carcinomas: insights, implications and clinical applications. Biomedicines 2024;12:1453.","DOI":"10.3390\/biomedicines12071453"},{"key":"3116_CR20","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Y Abuetabh","year":"2022","unstructured":"Abuetabh Y, Wu HH, Chai C, Al Yousef H, Persad S, Sergi CM, et al. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp Mol Med. 2022;54:1658\u201369.","journal-title":"Exp Mol Med"},{"key":"3116_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/cancers12020401","volume":"12","author":"LTS Fus\u00e9e","year":"2020","unstructured":"Fus\u00e9e LTS, Mar\u00edn M, F\u00e5hraeus R, L\u00f3pez I. Alternative mechanisms of p53 action during the unfolded protein response. Cancers (Basel). 2020;12:401.","journal-title":"Cancers (Basel)"},{"key":"3116_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22380","volume":"33","author":"MS Akhter","year":"2019","unstructured":"Akhter MS, Uddin MA, Barabutis N. Unfolded protein response regulates P53 expression in the pulmonary endothelium. J Biochem Mol Toxicol. 2019;33:e22380.","journal-title":"J Biochem Mol Toxicol"},{"key":"3116_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108342","volume":"684","author":"A Kumar","year":"2020","unstructured":"Kumar A, Kumar P, Kumari S, Uversky VN, Giri R. Folding and structural polymorphism of p53 C-terminal domain: one peptide with many conformations. Arch Biochem Biophys. 2020;684:108342.","journal-title":"Arch Biochem Biophys"},{"key":"3116_CR24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s43018-021-00259-9","volume":"2","author":"J Lehti\u00f6","year":"2021","unstructured":"Lehti\u00f6 J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, et al. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Nat Cancer. 2021;2:1224\u201342.","journal-title":"Nat Cancer"},{"key":"3116_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12672-024-00887-4","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang R, Huang Y, He J, Jin S, Li X, Tan K, et al. The endoplasmic reticulum stress-related genes and molecular typing predicts prognosis and reveals characterization of tumor immune microenvironment in lung squamous cell carcinoma. Discover Oncol. 2024;15:37.","journal-title":"Discover Oncol"},{"key":"3116_CR26","doi-asserted-by":"publisher","first-page":"1419468","DOI":"10.3389\/fphar.2024.1419468","volume":"15","author":"W Mu","year":"2024","unstructured":"Mu W, Zhi Y, Zhou J, Wang C, Chai K, Fan Z, et al. Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells. Front Pharmacol. 2024;15:1419468.","journal-title":"Front Pharmacol"},{"key":"3116_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101935","volume":"298","author":"VL Lastun","year":"2022","unstructured":"Lastun VL, Levet C, Freeman M. The mammalian rhomboid protein RHBDL4 protects against endoplasmic reticulum stress by regulating the morphology and distribution of ER sheets. J Biol Chem. 2022;298:101935.","journal-title":"J Biol Chem"},{"key":"3116_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12920-023-01785-4","volume":"17","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lin W, Qian H, Yang Y, Zhou X, Wu C, et al. Integrated multi-omic analysis and experiment reveals the role of endoplasmic reticulum stress in lung adenocarcinoma. BMC Med Genomics. 2024;17:12.","journal-title":"BMC Med Genomics"},{"key":"3116_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12964-018-0267-5","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao Y, Wang C, Ju H, Liu W, Zhang X, et al. Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels. Cell Commun Signal. 2018;16:65.","journal-title":"Cell Commun Signal"},{"key":"3116_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4149\/neo_2021_210804N1107","volume":"69","author":"ZY Xu","year":"2022","unstructured":"Xu ZY, Li X, Yao RH, Yang LM, Peng H, Ren WJ, et al. Rhomboid domain containing 1 promotes the growth of non-small cell lung cancer through the activation of EGFR and regulation of the BIK-mediated apoptosis. Neoplasma. 2022;69:311\u201320.","journal-title":"Neoplasma"},{"key":"3116_CR31","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1021\/acschembio.4c00273","volume":"19","author":"CC Davies","year":"2024","unstructured":"Davies CC, Hu R-M, Kamitsuka PJ, Morais GN, de Gonzalez RS, Bustin KA, et al. Activity-based protein profiling of RHBDL4 reveals proteolysis of the enzyme and a distinct inhibitor profile. ACS Chem Biol. 2024;19:1674\u201382.","journal-title":"ACS Chem Biol"},{"key":"3116_CR32","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.molcel.2022.06.024","volume":"82","author":"KM Ruff","year":"2022","unstructured":"Ruff KM, Choi YH, Cox D, Ormsby AR, Myung Y, Ascher DB, et al. Sequence grammar underlying the unfolding and phase separation of globular proteins. Mol Cell. 2022;82:3193-3208.e3198.","journal-title":"Mol Cell"},{"key":"3116_CR33","doi-asserted-by":"publisher","first-page":"111175","DOI":"10.1016\/j.celrep.2022.111175","volume":"40","author":"J Bock","year":"2022","unstructured":"Bock J, K\u00fchnle N, Knopf JD, Landscheidt N, Lee JG, Ye Y, et al. Rhomboid protease RHBDL4 promotes retrotranslocation of aggregation-prone proteins for degradation. Cell Rep. 2022;40:111175.","journal-title":"Cell Rep"},{"key":"3116_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107541","volume":"300","author":"YCM Penalva","year":"2024","unstructured":"Penalva YCM, Paschkowsky S, Recinto SJ, Duchesne A, Hammond T, Spiegler P, et al. Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4. J Biol Chem. 2024;300:107541.","journal-title":"J Biol Chem"},{"key":"3116_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2174\/011574888X259932231010112521","volume":"19","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yuan Y, Xia B. RHBDD1 promotes the growth and stemness characteristics of gastric cancer cells by activating Wnt\/\u03b2-catenin signaling pathway. Curr Stem Cell Res Ther. 2024;19:1021\u20138.","journal-title":"Curr Stem Cell Res Ther"},{"key":"3116_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12935-020-01516-0","volume":"20","author":"H Wang","year":"2020","unstructured":"Wang H, Chen X, Yang B, Xia Z, Chen Q. Mir-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1\/Wnt\/\u03b2-catenin signaling pathway. Cancer Cell Int. 2020;20:491.","journal-title":"Cancer Cell Int"},{"key":"3116_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41586-023-06253-8","volume":"619","author":"AM Kaiser","year":"2023","unstructured":"Kaiser AM, Gatto A, Hanson KJ, Zhao RL, Raj N, Ozawa MG, et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature. 2023;619:851\u20139.","journal-title":"Nature"},{"key":"3116_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/cancers14051143","volume":"14","author":"M Canale","year":"2022","unstructured":"Canale M, Andrikou K, Priano I, Cravero P, Pasini L, Urbini M, et al. The role of TP53 mutations in EGFR-mutated non-small-cell lung cancer: clinical significance and implications for therapy. Cancers (Basel). 2022;14:1143.","journal-title":"Cancers (Basel)"},{"key":"3116_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1158\/0008-5472.CAN-23-3929","volume":"84","author":"X Niu","year":"2024","unstructured":"Niu X, Martinez L. Harnessing p53 to improve immunotherapy for lung cancer treatment. Cancer Res. 2024;84:179\u201380.","journal-title":"Cancer Res"},{"key":"3116_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/0008-5472.CAN-21-1756","volume":"82","author":"E Dylgjeri","year":"2022","unstructured":"Dylgjeri E, Knudsen KE. DNA-PKcs: a targetable protumorigenic protein kinase. Cancer Res. 2022;82:523\u201333.","journal-title":"Cancer Res"},{"key":"3116_CR41","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1091\/mbc.e16-01-0032","volume":"27","author":"A Finzel","year":"2016","unstructured":"Finzel A, Grybowski A, Strasen J, Cristiano E, Loewer A. Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage. Mol Biol Cell. 2016;27:2360\u20137.","journal-title":"Mol Biol Cell"},{"key":"3116_CR42","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/neuonc\/noac105","volume":"24","author":"J Ding","year":"2022","unstructured":"Ding J, Li X, Khan S, Zhang C, Gao F, Sen S, et al. EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma. Neuro Oncol. 2022;24:1712\u201325.","journal-title":"Neuro Oncol"},{"key":"3116_CR43","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.18632\/oncotarget.378","volume":"2","author":"R Hill","year":"2011","unstructured":"Hill R, Madureira PA, Waisman DM, Lee P. DNA-PKCS binding to p53 on the p21WAF1\/CIP1 promoter blocks transcription resulting in cell death. Oncotarget. 2011;2:1094\u2013108.","journal-title":"Oncotarget"},{"key":"3116_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22:127\u201344.","journal-title":"Nat Rev Drug Discov"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03116-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:04:45Z","timestamp":1758881085000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03116-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03116-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"859"}}